Donor Killer Immunoglobulin-Like Receptor (KIR) Genotype-Patient Cognate KIR Ligand Combination and Antithymocyte Globulin Preadministration Are Critical Factors in Outcome of HLA-C-KIR Ligand-Mismatched T Cell–Replete Unrelated Bone Marrow Transplantation

This publication has 63 references indexed in Scilit:

• Global diversity and evidence for coevolution of KIR and HLA
  Nature Genetics, 2007
• Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT
  Blood, 2007
• Donor–Recipient Combinations of Group A and B KIR Haplotypes and HLA class I Ligand Affect the Outcome of HLA-Matched, Sibling Donor Hematopoietic Cell Transplantation
  Human Immunology, 2007
• Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation
  Clinical and Experimental Immunology, 2007
• Detrimental Effect of Natural Killer Cell Alloreactivity in T-replete Hematopoietic Cell Transplantation (HCT) for Leukemia Patients
  Transplantation and Cellular Therapy, 2007
• Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders
  Bone Marrow Transplantation, 2006
• The relevance of natural killer cell human leucocyte antigen epitopes and killer cell immunoglobulin‐like receptors in bone marrow transplantation
  Vox Sanguinis, 2005
• Homozygosity for human leucocyte antigen‐C ligands of KIR2DL1 is associated with increased risk of relapse after human leucocyte antigen‐C‐matched unrelated donor haematopoietic stem cell transplantation
  British Journal of Haematology, 2005
• MHC class I molecules and kirs in human history, health and survival
  Nature Reviews Immunology, 2005
• In search of the ‘missing self’: MHC molecules and NK cell recognition
  Published by Elsevier ,2003